Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118315) titled 'A Study to Evaluate Abrocitinib in the Treatment of Moderate to Severe Atopic Dermatitis in Adults' on Feb. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The People's Hospital of Dehong Prefecture
Condition:
Atopic Dermatitis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-20
Target Sample Size: Trial group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307176
Published by HT Digital Content Services with permission from Health Daily Digest....